Ice Quake

Description

icequakeplus is a pharmaceutical product with an effective date of September 27, 2013. It is presented in a media type of image/jpeg, with the reference image file named icequakeplus.jpg.

Uses and Indications

This drug is indicated for the temporary relief of minor pain associated with various conditions, including arthritis, simple backache, muscle strains, bruises, sprains, and cramps.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults and children over 12 years of age should apply IceQuake Plus to the affected area. The desired amount of gel should be squeezed onto the affected site and then massaged into the painful area until it is thoroughly absorbed. This application may be repeated as necessary, but should not exceed 3 to 4 times daily.

The route of administration is topical, and the method involves massaging the gel into the affected area. It is important to adhere to the recommended frequency of 3 to 4 times daily, as needed.

Contraindications

Use is contraindicated in children due to the risk of accidental ingestion. In the event of swallowing, immediate medical assistance or contact with a Poison Control Center is advised.

Warnings and Precautions

The product is intended for external use only. Healthcare professionals should advise patients to use the product strictly as directed. It is imperative to avoid bandaging the area tightly or using it in conjunction with a heating pad, as this may exacerbate adverse effects. Contact with the eyes and mucous membranes must be avoided to prevent irritation. The product should not be applied to wounds or any damaged, broken, or irritated skin.

In the event of a severe burning sensation, patients should discontinue use immediately. Additionally, it is crucial to instruct patients not to expose the treated area to heat or direct sunlight, as this may lead to further complications.

Patients are advised to stop using the product and consult a healthcare professional if their condition worsens, if redness occurs, or if any irritation develops.

In cases of ingestion, immediate medical assistance should be sought, or the patient should contact a Poison Control Center without delay.

Side Effects

Patients using this product should be aware of several important warnings and potential adverse reactions. This product is intended for external use only. When applying, it is crucial to avoid bandaging tightly or using it in conjunction with a heating pad. Contact with the eyes and mucous membranes should be strictly avoided, and the product must not be applied to wounds or any damaged, broken, or irritated skin.

In the event of a severe burning sensation, patients are advised to discontinue use immediately. Additionally, the treated area should not be exposed to heat or direct sunlight, as this may exacerbate adverse reactions.

Patients should stop using the product and consult a healthcare professional if their condition worsens, if redness develops, or if any irritation occurs. These precautions are essential to ensure the safe and effective use of the product.

Drug Interactions

There are no specific drug interactions or laboratory test interactions identified in the available data. Therefore, no dosage adjustments or monitoring recommendations are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Ice Quake (methyl salicylate, menthol, camphor). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be kept out of reach of children. In the event of accidental ingestion, immediate medical assistance or contact with a Poison Control Center is advised.

For children over 12 years of age, the recommended application involves applying the gel to the affected area. The patient should squeeze the desired amount of IceQuake Plus onto the area and massage the gel until it is thoroughly absorbed. This process may be repeated as necessary, but should not exceed 3 to 4 applications per day.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Pregnant patients should be aware that the safety of this medication during pregnancy has not been specifically established. There are no available data regarding the potential risks or fetal impacts associated with the use of this medication in pregnant individuals. Healthcare professionals are advised to consider the lack of information when prescribing this medication to women of childbearing potential and to weigh the potential benefits against any unknown risks. It is recommended that healthcare providers discuss the implications of medication use during pregnancy with their patients, ensuring informed decision-making.

Lactation

There are no specific warnings or recommendations regarding the use of this product by lactating mothers. Additionally, there are no known concerns related to the potential for excretion in breast milk or associated risks for breastfed infants.

Renal Impairment

Patients with renal impairment may not have specific information regarding dosage adjustments, special monitoring, or safety considerations outlined in the prescribing information. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment and monitoring of these patients.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include maintaining airway patency, ensuring adequate ventilation, and monitoring vital signs.

If available, the use of antidotes or specific treatments should be considered based on the clinical scenario and the substance involved. Consultation with a poison control center or a medical toxicologist may provide additional guidance on the management of overdose cases.

Documentation of the incident, including the substance, amount ingested, and time of ingestion, is crucial for effective management and treatment.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion. In the event that the medication is swallowed, patients should be instructed to seek medical help immediately or contact a Poison Control Center for assistance. It is important for patients to understand the urgency of the situation and the need for prompt action if ingestion occurs.

Storage and Handling

The product is supplied in configurations that include specific NDC numbers. It should be stored at room temperature, within the range of 20°C to 25°C (68°F to 77°F). It is essential to protect the product from light to maintain its integrity. Freezing is not permitted, as it may compromise the quality of the product. Additionally, the product should be discarded after opening to ensure safety and efficacy.

Additional Clinical Information

The route of administration for the product is topical. For adults and children over 12 years, the recommended application involves squeezing the desired amount of IceQuake Plus onto the affected area and massaging the gel into the painful area until it is thoroughly absorbed. This process may be repeated as necessary, but should not exceed 3 to 4 applications daily.

No additional information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Ice Quake, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)